Our research is focused on: 1. Identifying genetic markers for chemotherapy induced adverse drug reactions 2. the toxicity of new psychoactive substances & how to use post-mortem metabolomics. We develop prediction models using massive parallel sequencing, single cell RNASeq & high resolution chromatin conformation capture and bioinformatics with large clinical cohorts. In forensics, we develop new techniques using the CBRS platform for neuropharmacology as well as post-mortem metabolomics.
Henrik Green
Linköping University
Key Publications
Structure–metabolism relationships of 4-pentenyl synthetic cannabinoid receptor agonists using in vitro human hepatocyte incubations and high-resolution mass spectrometry
Archives of Toxicology, 2025
In vitro CB1 receptor activity of halogenated indazole synthetic cannabinoid receptor agonists
Archives of Toxicology, 2025
In vitro metabolism study of ADB‐P‐5Br‐INACA and ADB‐4en‐P‐5Br‐INACA using human hepatocytes, liver microsomes, and in‐house synthesized references
Drug Testing and Analysis, 2025
Unravelling the Genotype of the Apical Variant of Hypertrophic Cardiomyopathy in a Swedish Cohort
Genes, 2025
In vitro activation of the CB1 receptor by the semi‐synthetic cannabinoids hexahydrocannabinol (HHC), hexahydrocannabinol acetate (HHC‐O) and hexahydrocannabiphorol (HHC‐P)
Drug Testing and Analysis, 2025